Details for New Drug Application (NDA): 207931
✉ Email this page to a colleague
The generic ingredient in TECHNIVIE is ombitasvir; paritaprevir; ritonavir. Additional details are available on the ombitasvir; paritaprevir; ritonavir profile page.
Summary for 207931
Tradename: | TECHNIVIE |
Applicant: | Abbvie |
Ingredient: | ombitasvir; paritaprevir; ritonavir |
Patents: | 8 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 207931
Generic Entry Date for 207931*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 24, 2015 | TE: | RLD: | Yes | |||||
Patent: | 8,268,349*PED | Patent Expiration: | Feb 25, 2025 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | 8,399,015*PED | Patent Expiration: | Feb 25, 2025 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | 8,420,596*PED | Patent Expiration: | Oct 10, 2031 | Product Flag? | Substance Flag? | Delist Request? | Y |
Expired US Patents for NDA 207931
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | 6,037,157*PED | ⤷ Subscribe |
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | 7,364,752*PED | ⤷ Subscribe |
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | 7,148,359*PED | ⤷ Subscribe |
Abbvie | TECHNIVIE | ombitasvir; paritaprevir; ritonavir | TABLET;ORAL | 207931-001 | Jul 24, 2015 | 6,703,403*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription